Inactive Instrument

News Northwest Biotherapeutics, Inc. Other OTC

Equities

NWBO

US66737P6007

Summary

Unlock all the news: Be the first to know and act before the market!

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property	06-17	PR
Northwest Biotherapeutics: Q1 Earnings Snapshot	05-10	AQ
Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-10	CI
Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors	03-21	CI
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors	03-14	CI
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05	CI
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification	02-06	PR
Northwest Biotherapeutics announces that a Marketing Authorization Application has been submitted to the UK MHRA for DCVax-L for Glioblastoma	12-22	AQ
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma	12-21	PR
Northwest Biotherapeutics Announces Marketing Authorization Application Has Been Submitted to the UK MHRA for DCVax-L for Glioblastoma	12-21	CI
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application	11-22	PR
Northwest Biotherapeutics, Inc. announced that it has received $11.005 million in funding from Streeterville Capital, LLC	11-09	CI
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)	23-10-19	AQ
Northwest Biotherapeutics Provides Update on Near Term Plans for Submission of Marketing Authorization Application	23-10-16	AQ
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application	23-10-13	PR
Companies Spotlighted on "The Street Reports Podcast" Unveiling Secrets to Success: CLNV, HNRC, NWBO, ASRE	23-09-28	AQ
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)	23-09-25	AQ
Penny Stocks Set To Soar On News Watchlist (TBRIF, NWBO, IQST, TLOFF)	23-09-14	AQ
Today's OTC Momentum Watchlist (RGGI, DLOC, NWBO, HMBL)	23-09-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Northwest Biotherapeutics, Inc. Other OTC

Equities

NWBO

US66737P6007

Summary

Filters